This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gerlach, D. et al. Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 563, 705–709 (2018).
van Dalen, R. et al. Do not discard Staphylococcus aureus WTA as a vaccine antigen. Nature https://doi.org/10.1038/s41586-019-1416-8 (2019).
Driguez, P. A. et al. Immunogenic compositions against S. aureus. WO patent WO/2017/064190 (2017).
Hütter, J. & Lepenies, B. Carbohydrate-based vaccines: an overview. Methods Mol. Biol. 1331, 1–10 (2015).
Rappuoli, R. Glycoconjugate vaccines: principles and mechanisms. Sci. Transl. Med. 10, eaat4615 (2018).
Kalka-Moll, W. M. et al. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169, 6149–6153 (2002).
Weidenmaier, C., McLoughlin, R. M. & Lee, J. C. The zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism. PLoS ONE 5, e13227 (2010).
Wanner, S. et al. Wall teichoic acids mediate increased virulence in Staphylococcus aureus. Nat. Microbiol. 2, 16257 (2017).
Brown, S. et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc. Natl Acad. Sci. USA 109, 18909–18914 (2012).
Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410 (1999).
Xia, G. et al. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J. Biol. Chem. 285, 13405–13415 (2010).
Acknowledgements
Our work was financed by grants from the German Research Foundation to A.P. (TRR34, CRC766, TRR156 and RTG1708) and T.S. (TRR34, CRC766) and the German Center for Infection Research and is supported by infrastructure provided by the Cluster of Excellence (EXC 2124).
Author information
Authors and Affiliations
Contributions
D.G, Y.G., T.S. and A.P analysed data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gerlach, D., Guo, Y., Stehle, T. et al. Reply to: Do not discard Staphylococcus aureus WTA as a vaccine antigen. Nature 572, E3–E4 (2019). https://doi.org/10.1038/s41586-019-1417-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-019-1417-7
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.